Skip to main content
. 2018 Oct 12;21(3):370–379. doi: 10.1093/neuonc/noy164

Table 3.

Median survival times (point estimate with 95% CI) in months

Outcome Median Survival Time (95% CI)
Time Period 2000–2006 2007–2013
All patients 7.5 (6.8–8.2) 9.6 (9.1–10.2)
 ≤70 9.3 (8.6–10.1) 11.7 (11.0–12.5)
 >70 3.6 (3.2–4.1) 4.5 (3.8–5.1)
Age group
 18–40 17.0 (11.1–22.0) 19.7 (13.7–25.1)
 41–50 11.8 (10.2–13.2) 17.3 (14.5–19.5)
 51–60 9.9 (9.2–11.2) 12.4 (11.3–13.8)
 61–70 6.7 (5.6–7.8) 9.3 (8.3–9.9)
 71–80 4.2 (3.6–5.2) 5.2 (4.5–5.8)
 >80 2.0 (1.3–2.6) 2.3 (1.4–3.1)
Sex and age
Men 8.1 (7.1–8.9) 9.9 (9.2–10.8)
 ≤70 9.8 (8.6–11.1) 11.8 (10.9–12.7)
 >70 3.6 (3.1–4.3) 4.8 (3.8–5.5)
Women 6.7 (5.7–7.8) 9.2 (8.2–10.1)
 ≤70 8.9 (7.8–9.8) 11.7 (10.3–13.3)
 >70 3.7 (2.8–4.6) 4.2 (3.3–5.2)

The estimates are age-standardized and can be compared between the two periods. Survival time shown in months.

Data from the Finnish Cancer Registry.